Novo Nordisk Shares Rise After Withdrawal from Metsera Takeover Battle

Shares climbed as much as 3.5% in early European trade after Pfizer agreed to buy Metsera in a deal that could be worth more ...
PharmExec

Novo Nordisk Not Planning Increased Proposal Offer After Metsera Enters $10 Billion Amended Merger Agreement with Pfizer

On November 4, 2025, just a day after Pfizer filed its suits against Novo Nordisk and Metsera, Novo Nordisk submitted an ...

Novo Nordisk: Buy This Bargain

Novo Nordisk A/S posted solid revenue and profit increases, with a resilient pipeline and strong dividend yield. Learn more ...

How Recent Developments Are Shaping the Investment Story for Novo Nordisk

Novo Nordisk's consensus analyst price target has recently been revised downward from DKK 438.59 to DKK 431.99, marking a modest decrease in sentiment. This adjustment comes amid a modest uptick in ...

Novo Nordisk shares rise on investor relief after it exits Metsera bid

Pedersen COPENHAGEN (Reuters) -Shares in Novo Nordisk rose on Monday after the Wegovy maker lost out to Pfizer in a $10 ...

Novo Nordisk gives up battle for Metsera as Pfizer inks $10B deal

Pfizer (PFE) wins Metsera (MTSR) buyout after a heated bidding war with Novo Nordisk (NVO), securing a $10B deal for the ...

Pfizer adquiere Metsea, desarrolladora de fármacos contra la obesidad, tras puja con Novo Nordisk

El gigante farmacéutico estadounidense Pfizer firmó un acuerdo para adquirir Metsera Inc., la empresa desarrolladora de ...
BioSpace

Novo Execs Face Skeptical Analysts Amid Metsera Buyout Drama

Investors got to hear Novo Nordisk’s side of the Metsera bidding war drama for the first time on Wednesday, as the company ...